Publications by authors named "Y Kanda"

Claim this Profile
N
Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation.
Yasutaka Sadaga, Yuho Najima, Takayoshi Tachibana, Kaito Harada, Takuya Miyazaki, Yoshinobu Kanda

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantation.
Shun-Ichi Kimura, Shunto Kawamura, Takashi Toya, Keiji Okinaka, Hiroki Hosoi, Yoshinobu Kanda

J Infect Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model.
Masato Saito, Kana Kunieda, Toshihiko Ishii, Shoko Koshiba, Rui Ohashi, Yutaka Kanda

Cancer Immunol Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Vascular Endothelial Growth Factor-A Identified by Proximity Extension Assay Predicts Early Progression in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.
Kazuaki Tajima, Satoshi Miuma, Ryu Sasaki, Yasuko Kanda, Satoshi Matsuo

Hepatol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma: A Nationwide Registry Analysis.
Makoto Yoshimitsu, Hidehiro Itonaga, Koji Kato, Masahito Tokunaga, Machiko Fujioka, Yoshinobu Kanda

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis